Shenzhen YHLO Biotech Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

0.04

Vol. 1Y

—

Shs. 5Y

3.39%

Rev. 5Y

12.61%

Div Yld LY

—

Div Yld TTM

—

Revenues

1.81b

-10.07%

Net income

23m

-92.26%

CFO

422m

-20.39%

Dividend

Jun 12, 20260.021 /sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

URL

https://www.szyhlo.com/

IPO date

May 17, 2021

Employees

Domiciled in

Incorporated in

Headquarters & legal address

深圳市龙岗区宝龙街道宝龙二路亚辉龙生物科技厂区1栋
深圳市, GD 510000
CN

Valuation

Latest on right Latest on left

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2021‑00	2020‑12	2019‑12	2018‑12	2017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT